News for 'life-sciences'

Meet C Vijayakumar, Shiv Nadar's successor at HCL Tech

Meet C Vijayakumar, Shiv Nadar's successor at HCL Tech

Rediff.com9 Aug 2021

C Vijayakumar, the reticent chief executive of HCL Technologies, India's third-largest IT services firm, was recently appointed managing director, succeeding the founder, Shiv Nadar. Back in October 2016, when CVK, as he is popularly called within and outside of HCL, was named CEO, it had been somewhat of a surprise - his elevation being the result of his predecessor, Anant Gupta, suddenly stepping down to "pursue personal interests". CVK, 53, has since taken the firm from under $7 billion to over $10 billion in revenue.

Indian pharma firms working on new repurposed drug for Covid-19

Indian pharma firms working on new repurposed drug for Covid-19

Rediff.com2 Sep 2020

Many companies globally are working on plasma research to develop and manufacture hyperimmune globulin therapies from plasma donations.

Hetero's generic version of remdesivir to be sold @ Rs 5,400/vial

Hetero's generic version of remdesivir to be sold @ Rs 5,400/vial

Rediff.com24 Jun 2020

The company is set to deliver the first set of 20,000 vials in two equal lots of 10,000 each, one of which will be immediately supplied to Hyderabad, Delhi, Gujarat, Tamil Nadu, Mumbai and other parts of Maharashtra, Hetero Healthcare said in a statement.

Govt places order for 11 mn doses of Serum vaccine Covishield

Govt places order for 11 mn doses of Serum vaccine Covishield

Rediff.com11 Jan 2021

Dispatch of the vaccine is likely to start by early Tuesday morning, sources said. According to the order placed, each dose of the vaccine has been priced at Rs 200 and with GST of Rs 10, it would cost Rs 210.

Big 3 IT companies to hire 75,000 campus freshers

Big 3 IT companies to hire 75,000 campus freshers

Rediff.com26 Apr 2021

Attrition is driving the hiring effort on campuses.

It's raining IPOs! 40-odd issues to mop up Rs 80K cr

It's raining IPOs! 40-odd issues to mop up Rs 80K cr

Rediff.com7 Jul 2021

The primary market is set for a bumper Rs 80,000-crore bonanza with 30 companies already filing IPO papers to raise Rs 55,000 crore, while around 10 more are lined up for this month itself, seeking to mop up another Rs 25,000 crore, say investment bankers. The market has been on a non-stop rally, hitting new records almost every week, on the back of an influx of investors -- a vast majority of them first-timers -- coupled with a flood of liquidity. Foreign funds alone had pumped in a record $35 billion into the market in FY21, while the trend has continued this fiscal as well. Domestic institutions led by LIC have also infused trillions of rupees, helping woo retail investors in troves -- the year saw over 20 million new investors coming to the market.

6 professors awarded Infosys Prize 2019 for science and research

6 professors awarded Infosys Prize 2019 for science and research

Rediff.com7 Nov 2019

The annual award includes a pure gold medal, a citation and a prize purse worth $ 100,000 or its equivalent in the Indian rupees.

Gas leak at pharma plant in Vizag leaves 2 dead

Gas leak at pharma plant in Vizag leaves 2 dead

Rediff.com30 Jun 2020

The leakage of benzimidazole gas occurred at Sainor Life Sciences Pvt Ltd in Visakhapatnam on Monday night.

'Putin is a goonda'

'Putin is a goonda'

Rediff.com28 Mar 2022

'Sholay wallah kahani hai: 'Gabbar Singh aayega, Gabbar Singh aayega.' 'But what is inside Gabbar Singh nobody knows.'

ASK AJIT: Stocks To Buy, Sell, Hold

ASK AJIT: Stocks To Buy, Sell, Hold

Rediff.com24 Jan 2022

Ajit Mishra, vice president, research, Religare Broking, answers your queries.

'Salaries to go up 10.7%, star performers to gain handsomely'

'Salaries to go up 10.7%, star performers to gain handsomely'

Rediff.com24 Jul 2016

Despite the recent slowdown, e-commerce tops the projected average salary hike list

Infosys CEO Salil Parekh draws Rs 34.27 cr pay package in FY20

Infosys CEO Salil Parekh draws Rs 34.27 cr pay package in FY20

Rediff.com2 Jun 2020

Infosys chairman Nandan Nilekani voluntarily chose not to receive any remuneration for his services.

Why you should not expect a great salary hike in 2015

Why you should not expect a great salary hike in 2015

Rediff.com11 Dec 2014

India Inc likely to keep average salary hikes at 11 per cent in 2015, with medical life sciences sector expected to dole out the highest pay raise, says a survey by Mercer.

PE/VC investments in pharma cos cross $1 bn mark

PE/VC investments in pharma cos cross $1 bn mark

Rediff.com6 Oct 2020

Fund managers said investors remained positive on the pharma manufacturing activity in India, which further strengthened during the Covid-19 period, on account of restrictions imposed on pharma imports from China.

Covid vaccine: Pharma firms ready expansion plans

Covid vaccine: Pharma firms ready expansion plans

Rediff.com6 Oct 2020

The Indian vaccine industry largely feels there are two ways in which vaccine innovation can be spurred - one, get a high price for the product and two, have the government buy a few hundred million doses of the product at a certain price.

You are likely to get 10.5% salary hike this year

You are likely to get 10.5% salary hike this year

Rediff.com14 Jan 2016

In 2016, one in two companies is planning to increase head count with hi-tech, shared services and life sciences leading the pack

Booster dose of anti-Covid vax not needed at this stage: Experts

Booster dose of anti-Covid vax not needed at this stage: Experts

Rediff.com18 Sep 2021

As the global debate on booster shots gathers momentum, several scientists in New Delhi said the priority must be to ensure that more people are inoculated with at least their first jab.

Jameel announced resignation in meeting of INSACOG, left colleagues surprised

Jameel announced resignation in meeting of INSACOG, left colleagues surprised

Rediff.com17 May 2021

Scientists associated with Indian SARS-CoV-2 Consortium on Genomics (INSACOG), the government panel that conducts research on different variants of the coronavirus, said they were surprised at noted virologist Shahid Jameel's decision to quit the group and wondered whether he was disillusioned with the government's handling of the pandemic.

Reliance Life catches US firm's eye

Reliance Life catches US firm's eye

Rediff.com20 Nov 2006

Stem cell research major GlobalStem in talks for a strategic alliance.

Utah governor presents lifetime achievement award to Dr Dinesh Patel

Utah governor presents lifetime achievement award to Dr Dinesh Patel

Rediff.com27 Dec 2013

Dinesh Patel, Utah's most high profile and influential Indian American, was conferred the Willem J Kolff Lifetime Achievement Award at BioUtah's 2013 Utah Life Science Award, the state's top science award ceremony.

Ask Ajit: 'Want to invest Rs 2 lakhs, please advise'

Ask Ajit: 'Want to invest Rs 2 lakhs, please advise'

Rediff.com22 Nov 2021

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

WHO reminds Serum Institute of COVAX commitments

WHO reminds Serum Institute of COVAX commitments

Rediff.com18 May 2021

COVAX, 'the global COVID vaccine equity scheme', has so far delivered 65 million doses to 124 countries and economies but it is dependent on countries and manufacturers honouring their commitments.

Work for a pharmaceutical firm

Work for a pharmaceutical firm

Rediff.com2 Feb 2005

RPG Life Sciences Ltd, the pharmaceutical arm of RPG Enterprises, is recruiting sales officers and district managers.

After Najeeb, another JNU student 'goes missing'

After Najeeb, another JNU student 'goes missing'

Rediff.com10 Jan 2018

Mukul Jain, enrolled in Life Sciences course, has been missing since January 8.

Employees in India likely to get average salary hike 9.7% in 2019

Employees in India likely to get average salary hike 9.7% in 2019

Rediff.com6 Mar 2019

Only five sectors such as consumer internet companies, professional services, life sciences, automotive and consumer products are projecting double-digit increment.

Piramal Life may develop TB drug

Piramal Life may develop TB drug

Rediff.com17 Sep 2008

Piramal Life Sciences may become the first company to successfully develop a tuberculosis drug whose leads isolated from the living organisms found in ice brought from the Antarctica region. "(Our) scientists have identified additional leads that will help develop drugs to treat tuberculosis and other infections," revealed Swati Piramal, director, Nicholas Piramal.

Reliance arm to reap big gains from biodiesel

Reliance arm to reap big gains from biodiesel

Rediff.com27 Mar 2009

Mukesh Ambani's privately held biotech research company, Reliance Life Sciences, will soon diversify to take up biofuel production in a major way. Industry sources said the facilities might require an investment of Rs 150-200 crore (Rs 1.5 billion to Rs 2 billion). One hectare of land yields about a tonne of crop, so RLS will need to cultivate about one lakh hectares of land, they say. The majority of investments go into sourcing raw material, they say.

15 most attractive countries for expatriate workforce

15 most attractive countries for expatriate workforce

Rediff.com17 Sep 2013

Let's take a look at nations most attractive to those seeking employment overseas.

Trainees for agri products

Trainees for agri products

Rediff.com16 May 2007

Gujarat Life Sciences (P) Ltd is looking for trainees / executives interested in marketing and sales of microbial products.

Ambani says will provide tech for COVID-19 vaccination drive

Ambani says will provide tech for COVID-19 vaccination drive

Rediff.com15 Dec 2020

As India gets ready to roll out one of the largest vaccine programmes, billionaire Mukesh Ambani on Tuesday said his group is working with authorities to provide technology tools and backbone for mass inoculation against COVID-19. Ambani's telecom venture Jio was rolled out four years back, offering free voice calling and dirt-cheap data. Today, Jio is India's largest telecom operator with over 400 million users, each connected to the internet. At a Facebook event, Ambani said the government's digital push kept the country running even during the pandemic and is now helping in the rollout of one of the largest vaccination programmes.

COVID-19 test kits should be made available at lowest cost: HC

COVID-19 test kits should be made available at lowest cost: HC

Rediff.com26 Apr 2020

Justice Najmi Waziri issued the direction to three private companies which had entered into an agreement to import 10 lakh test kits from China and distribute them here at a cost of Rs 600 each, the rate approved by the Indian Council of Medical Research (ICMR).

RIL forging Indo-US ties in many sectors: Ambani

RIL forging Indo-US ties in many sectors: Ambani

Rediff.com28 Jun 2007

India's most valued company Reliance Industries is building partnership with the US in many of the sunrise areas like life-sciences, biotechnology and retail.

Cognizant to buy US firm for $135 mn

Cognizant to buy US firm for $135 mn

Rediff.com20 Oct 2007

IT services major Cognizant Technology Solutions Corporation is strengthening its capabilities in the life sciences segment by acquiring New Jersey-based marketRx, provider of analytics and software services to global life sciences companies, for $135 million.

Funds fight for front row seat in India

Funds fight for front row seat in India

Rediff.com11 Dec 2007

Many view private equity-related funds as a better way of capturing the upside in the economy, given that stock market valuations have been swollen by three to four years of almost uninterrupted share price rises.

Money laundering: Did RIL subsidiary violate norms?

Money laundering: Did RIL subsidiary violate norms?

Rediff.com21 Jul 2014

An investigation by government agencies is under progress into the alleged violation of rules in investments made by Singapore-based Biometrix Marketing, a Reliance Industries (RIL) group firm.

United Phos, Rallis eye $2 bn buy in Japan

United Phos, Rallis eye $2 bn buy in Japan

Rediff.com11 Sep 2007

Arysta, the target, is a leading crop protection and life sciences firm.

2 Indian firms in WEF Technology Pioneers list

2 Indian firms in WEF Technology Pioneers list

Rediff.com4 Dec 2006

Two Indian companies -- Strand Life Sciences and Drishtee -- are among 47 'visionary' firms worldwide selected by the World Economic Forum as Technology Pioneers 2007 for their life-changing innovations.

India rejects Google's patent plea for e-shoe

India rejects Google's patent plea for e-shoe

Rediff.com29 Feb 2020

The patent application for 'System and method for wearable electronic devices', filed in 2007, mentions various wearable models including a shoe that can communicate data to the user, electronic communication devices attached to clothes, wireless ear pieces and ankle bracelets that can transmit updated information from the body to the user. The drawings the company submitted to the patent office also show the design of a shoe that can be a wearable electronic device.